0000899243-20-018288.txt : 20200702
0000899243-20-018288.hdr.sgml : 20200702
20200702162808
ACCESSION NUMBER: 0000899243-20-018288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Turtle Cameron
CENTRAL INDEX KEY: 0001758363
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 201009776
MAIL ADDRESS:
STREET 1: C/O EIDOS THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-30
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001758363
Turtle Cameron
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
0
1
0
0
See Remarks
Common Stock
2020-06-30
4
M
0
6000
0.16
A
15823
D
Common Stock
2020-06-30
4
M
0
4000
0.34
A
19823
D
Common Stock
2020-06-30
4
S
0
9700
32.6465
D
10123
D
Common Stock
2020-06-30
4
S
0
300
33.1733
D
9823
D
Stock Option (Right to Buy)
0.16
2020-06-30
4
M
0
6000
0.00
D
2020-05-19
2029-05-23
Common Stock
6000
68042
D
Stock Option (Right to Buy)
0.34
2020-06-30
4
M
0
4000
0.00
D
2020-05-19
2029-07-14
Common Stock
4000
45766
D
Represents the weighted average sale price of the shares sold from $32.12 to $33.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2.
Represents the weighted average sale price of the shares sold from $33.13 to $33.23 per share.
Senior Vice President, Portfolio Management and Corporate Development
/s/ Tara Condon, Attorney-in-Fact
2020-07-02